Lilly increases manufacturing investment to US$ 9 billion at newest Indiana site
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
A five-day inspection was concluded successfully with no critical and no major observations raised
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Subscribe To Our Newsletter & Stay Updated